BG103196A - Кристален фармацевтичен продукт - Google Patents

Кристален фармацевтичен продукт

Info

Publication number
BG103196A
BG103196A BG103196A BG10319699A BG103196A BG 103196 A BG103196 A BG 103196A BG 103196 A BG103196 A BG 103196A BG 10319699 A BG10319699 A BG 10319699A BG 103196 A BG103196 A BG 103196A
Authority
BG
Bulgaria
Prior art keywords
pharmaceutical product
crystalline pharmaceutical
crystalline
3oxo
bipiperidin
Prior art date
Application number
BG103196A
Other languages
English (en)
Inventor
Stephen Ross
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of BG103196A publication Critical patent/BG103196A/bg

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Изобретението се отнася до (S)-7-[(4,4'-бипиперидин-1-ил)карбонил]-2,3,4,5-тетрахидро-4-метил-3-оксо-1Н-1,4-бензодиазепин-2-оцетна киселина, хидрохлорид, метод за получаване и неговото използване.
BG103196A 1996-09-03 1999-02-22 Кристален фармацевтичен продукт BG103196A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2536996P 1996-09-03 1996-09-03
PCT/US1997/015292 WO1998009629A1 (en) 1996-09-03 1997-08-29 Crystalline pharmaceutical product

Publications (1)

Publication Number Publication Date
BG103196A true BG103196A (bg) 1999-09-30

Family

ID=21825633

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103196A BG103196A (bg) 1996-09-03 1999-02-22 Кристален фармацевтичен продукт

Country Status (32)

Country Link
US (1) US6335330B1 (bg)
EP (1) EP0964684B1 (bg)
JP (1) JP2000517342A (bg)
CN (1) CN1102391C (bg)
AP (1) AP9901472A0 (bg)
AR (1) AR008154A1 (bg)
AT (1) ATE245984T1 (bg)
AU (1) AU731173B2 (bg)
BG (1) BG103196A (bg)
BR (1) BR9711981A (bg)
CA (1) CA2264607A1 (bg)
CO (1) CO4930262A1 (bg)
CZ (1) CZ71999A3 (bg)
DE (1) DE69723873T2 (bg)
DZ (1) DZ2302A1 (bg)
EA (1) EA001363B1 (bg)
ES (1) ES2205254T3 (bg)
HU (1) HUP9904077A3 (bg)
ID (1) ID18156A (bg)
IL (1) IL128782A0 (bg)
MA (1) MA24309A1 (bg)
MY (1) MY118175A (bg)
NO (1) NO991013L (bg)
NZ (1) NZ334438A (bg)
OA (1) OA10986A (bg)
PE (1) PE107198A1 (bg)
PL (1) PL332006A1 (bg)
SK (1) SK27699A3 (bg)
TR (1) TR199900480T2 (bg)
UY (1) UY24690A1 (bg)
WO (1) WO1998009629A1 (bg)
ZA (1) ZA977870B (bg)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19902529A1 (de) * 1999-01-22 2000-08-03 Goldwell Gmbh Haarbehandlungsmittel
FR2797400A1 (fr) * 1999-08-11 2001-02-16 Sanofi Synthelabo Associations a activite anti-thrombotique constituees de l'hydrogenosulfate de clopidogrel et d'un antagoniste des recepteurs gpiib/iiia et les compositions pharmaceutiques les contenant
CA2464472C (en) 2001-10-22 2014-01-07 The Scripps Research Institute Antibody targeting compounds
US20050202151A1 (en) * 2004-03-15 2005-09-15 Land O'lakes, Inc. Method of preparing egg nuggets
KR101046977B1 (ko) * 2004-11-15 2011-07-07 삼성에스디아이 주식회사 카본나노튜브, 이를 포함한 전자 방출원 및 이를 구비한전자 방출 소자
US20070122408A1 (en) * 2005-10-20 2007-05-31 The Scripps Research Institute Fc Labeling for Immunostaining and Immunotargeting
US8518927B2 (en) 2009-02-10 2013-08-27 The Scripps Research Institute Chemically programmed vaccination

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD138319A1 (de) * 1978-08-08 1979-10-24 Helmut Roehnert Verfahren zur herstellung einer stabilen,kristallwasser-und kristalloesungsmittelfreien kristallform des 7-chlor-2-methylamino-5-phenyl-3h-1,4-benzodiazepin-4-oxid-hydrochlorids
US5939412A (en) 1992-06-26 1999-08-17 Smithkline Beecham Corporation Bicyclic fibrinogen antagonists
PT100631B (pt) 1991-06-28 1999-06-30 Smithkline Beecham Corp Antagonistas biciclicos de fibrinogenio, seu uso e composicoes farmaceuticas que os contem
SG63579A1 (en) 1992-12-21 1999-03-30 Smithkline Beecham Corp Bicyclic fibrinogen antagonists
MA23420A1 (fr) * 1994-01-07 1995-10-01 Smithkline Beecham Corp Antagonistes bicycliques de fibrinogene.

Also Published As

Publication number Publication date
EP0964684A1 (en) 1999-12-22
CZ71999A3 (cs) 1999-08-11
NO991013D0 (no) 1999-03-02
EP0964684B1 (en) 2003-07-30
WO1998009629A1 (en) 1998-03-12
CN1102391C (zh) 2003-03-05
CN1234739A (zh) 1999-11-10
ES2205254T3 (es) 2004-05-01
NZ334438A (en) 2000-10-27
MY118175A (en) 2004-09-30
DE69723873D1 (de) 2003-09-04
TR199900480T2 (xx) 1999-06-21
JP2000517342A (ja) 2000-12-26
AU731173B2 (en) 2001-03-22
DE69723873T2 (de) 2004-04-22
UY24690A1 (es) 1998-02-27
PL332006A1 (en) 1999-08-16
EP0964684A4 (en) 2002-05-29
EA199900260A1 (ru) 1999-08-26
MA24309A1 (fr) 1998-04-01
HUP9904077A2 (hu) 2000-05-28
ID18156A (id) 1998-03-05
HUP9904077A3 (en) 2002-03-28
BR9711981A (pt) 1999-08-24
CO4930262A1 (es) 2000-06-27
SK27699A3 (en) 2000-02-14
AU4242597A (en) 1998-03-26
CA2264607A1 (en) 1998-03-12
EA001363B1 (ru) 2001-02-26
NO991013L (no) 1999-03-02
AR008154A1 (es) 1999-12-09
ZA977870B (en) 1998-03-03
ATE245984T1 (de) 2003-08-15
PE107198A1 (es) 1999-03-21
IL128782A0 (en) 2000-01-31
US6335330B1 (en) 2002-01-01
OA10986A (en) 2003-03-04
DZ2302A1 (fr) 2002-12-28
AP9901472A0 (en) 1999-03-31

Similar Documents

Publication Publication Date Title
HUP9602122A3 (en) Camptothecin derivatives, process for the preparation thereof and pharmaceutical compositions containing them
IL127798A (en) N-substituted indol-3-glyoxylamides, process for their preparation and pharmaceutical compositions comprising them
HUP9603494A3 (en) Hydroxycarboxamide derivatives, pharmaceutical compositions containing them, process for the preparation thereof
ZA968945B (en) 1,3-Dihydro-indol-2-one derivatives process for their preparation and the pharmaceutical compositions containing them
ZA968850B (en) Phenylacetic acid derivatives, processes and intermediate for their preparation, and compositions comprising them.
HUP0204170A3 (en) 5-thia-omega-substituted phenyl-prostaglandin e derivatives, process for producing the same and drugs containing the same as the active ingredient
HUP9701264A3 (en) Aminoacid derivatives, process for producing them and pharmaceutical compositions containing them
HUP9701265A3 (en) Imidazoline derivatives, process for producing them and pharmaceutical compositions containing them
HUP9802653A3 (en) Substituted imidazolidine derivatives, process for producing them, and pharmaceutical compositions containing them
HUP0001555A3 (en) Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation
HUP9700574A3 (en) N,n-dimethyl-(3-aryl-but-3-ene)-amine derivatives, pharmaceutical compositions containing them and process for the preparation thereof
IL140897A0 (en) Benzocycloheptene derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
PL344219A1 (en) Gamma-aminobutyric acid derivatives containing, solid compositions and process for preparing the same
HUP9901739A3 (en) Aminoisoquinolines and aminothienopyridine derivatives, process for producing thereof and pharmaceutical compositions containing them
HUP0102215A3 (en) Benzoylpyridazines, pharmaceutical compositions containing the same and process for their preparation
HUP9901473A3 (en) 2,3-benzodiazepine derivatives, process for producing them and pharmaceutical compositions containing them
AU1166895A (en) Polysubstituted 3-acylamino-5-phenyl-1,4-benzodiazepin-2-onederivatives, process for their preparation and the pharmaceutical compositions containing them
HK1039122A1 (zh) 取代的6-苄基-4-氧代嘧啶,其製備方法以及含該化合物的藥物組合物
ZA9610460B (en) New phenylamidine derivatives, processes for preparing them and their use as pharmaceutical compositions.
HUP9701660A3 (en) 10,13,15-trioxatricyclo[9.2.1.1.9.6]pentadekanon derivatives, process for producing them, and pharmaceutical compositions containing them
HUP9602868A3 (en) 1,7,7-trimethyl-bicyclo[2.2.1]heptane derivative, pharmaceutical compositions containing the same and process for their preparation
HUP0004588A3 (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine-10-oles, method for the production and use thereof as medicaments and pharmaceutical compositions containing them
BG103196A (bg) Кристален фармацевтичен продукт
HUP0102609A3 (en) N-phenyl-n'-phenylpropylpiperazine derivatives and process for the preparation thereof, and pharmaceutical compositions containing them
HUP0104202A3 (en) Thiazole-derivatives, process for their preparation and pharmaceutical compositions containing them